Results 191 to 200 of about 31,441 (254)

Left atrial appendage occlusion

EuroIntervention, 2017
Left atrial appendage occlusion (LAAO) is a first-line therapy for stroke prevention in patients suffering from atrial fibrillation (AF). While patients at high risk for bleeding or patients with previous bleeding have the highest relative risk reduction from LAAO, it is the younger patients with a high lifetime bleeding risk who benefit from the ...
Nietlispach F, Moarof I, Taramasso M, Maisano F, Meier B   +4 more
openaire   +3 more sources

2025 SCAI/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion.

Heart Rhythm
BACKGROUND Left atrial appendage occlusion (LAAO) devices reduce the risk of atrial fibrillation-associated stroke relative to no oral anticoagulation. However, uncertainty and practice variation persist in the areas of patient selection, periprocedural ...
A. Goldsweig, M. Glikson, Jacqueline Joza, Clifford J. Kavinsky, Omar Khalique, Dhanunjaya Lakkireddy, G. Mackensen, G. Naccarelli, Devi G. Nair, Jacqueline Saw, R. Sharma, Matthew Sherwood, Molly I. Szerlip, Yngve Falck-Ytter, Rebecca L. Morgan, Chelsea Armah, Scott Firestone, Angela M. Fix, Emily Senerth, C. Ellis   +19 more
semanticscholar   +2 more sources

Percutaneous Left Atrial Appendage Occlusion

Revista Española de Cardiología (English Edition), 2013
La fibrilacion auricular de origen no valvular (FANV) es la arritmia mas frecuente en nuestro medio. Su incidencia guarda estrecha relacion con la edad, con una prevalencia cercana al 25% en pacientes mayores de 80 anos 1 .
Xavier, Freixa, Victoria, Martín-Yuste
openaire   +2 more sources

Transcatheter Left Atrial Appendage Occlusion

Cardiology Clinics, 2013
Occlusion of the left atrial appendage (LAA) may reduce the risk of stroke in patients with atrial fibrillation (AF). Trials comparing LAA occlusion to warfarin anticoagulation in patients with nonvalvular AF showed a reduction in hemorrhagic stroke, although an increase in safety events due to procedural complications.
Creighton W, Don, Cindy J, Fuller, Mark, Reisman   +2 more
openaire   +2 more sources

Republished: Left atrial appendage occlusion

Postgraduate Medical Journal, 2015
ABSTRACTLeft atrial appendage (LAA) occlusion for stroke and thromboembolism prevention in patients with atrial fibrillation (AF) represents a significant advancement in the field of cardiovascular disease. Prevention and avoidance of the devastating consequences of thromboembolic complications from AF continues to be central in the management of these
Oluseun, Alli, David, Holmes
openaire   +2 more sources

Left Atrial Appendage Occlusion in Nonagenarians

Journal of Invasive Cardiology, 2022
Nonagenarians constitute a fast-growing and high-risk segment of the population, with scarce data on specific outcomes for percutaneous left atrial appendage occlusion (LAAO). The aim of the present paper was to assess the outcomes of nonagenarian patients undergoing LAAO from the prospective global Amplatzer Amulet observational study.
Pedro Cepas-Guillén, Boris Schmidt, Sergio Berti, Sven Fischer, Kai Magnusson, Carsten Skurk, Tobias Zeus, Xavier Freixa   +7 more
openaire   +2 more sources

Device-Related Thrombus After Left Atrial Appendage Occlusion: Clinical Impact, Predictors, Classification, and Management.

JACC: Cardiovascular Interventions, 2023
Despite the unprecedented advances in the left atrial appendage occlusion field, device-related thrombus (DRT) remains an unresolved issue with the therapy. This paper aims to provide a state-of-the-art review of the literature on the incidence, clinical
M. Alkhouli, Hasan S. Alarouri, A. Kramer, K. Korsholm, Jeremy D. Collins, O. de Backer, H. Hatoum, J. Nielsen-Kudsk   +7 more
semanticscholar   +1 more source

LEFT ATRIAL APPENDAGE OCCLUSION FOLLOWING LEFT ATRIAL APPENDAGE ISOLATION

Journal of the American College of Cardiology, 2018
LAA isolation is an important adjunctive ablation strategy in patients with non-paroxysmal AF. Given the high prevalence of poor contractile function of the LAA, the risk of stroke in this cohort is high and OAC is recommended despite maintenance of SR.
Varuna Gadiyaram, Carola Gianni, Chintan Trivedi, Sanghamitra Mohanty, Domenico Della Rocca, Amin Al-Ahmad, John Burkhardt, G. Gallinghouse, Patrick Hranitzky, Javier Sanchez, Luigi Di Biase, Rodney Horton, Matthew Price, Douglas Gibson, Andrea Natale   +14 more
openaire   +1 more source

Causal Machine Learning for Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.

JACC Clinical Electrophysiology
BACKGROUND Transcatheter left atrial appendage occlusion (LAAO) is an alternative to lifelong anticoagulation, but optimal patient selection remains challenging.
Che Ngufor, Nan Zhang, Holly K Van Houten, D. Holmes, Jonathan Graff‐Radford, M. Alkhouli, Paul A. Friedman, P. Noseworthy, Xiaoxi Yao   +8 more
semanticscholar   +1 more source

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.

JAMA cardiology
Importance Optimal antithrombotic therapy after percutaneous left atrial appendage occlusion (LAAO) is not well established as no randomized evaluation has been performed to date.
X. Freixa, Ignacio Cruz-González, P. Cepas-Guillen, Xavier Millan, Pablo J Antúnez-Muiños, E. Flores-Umanzor, L. Asmarats, A. Regueiro, S. López-Tejero, Chi Hion Pedro Li, L. Sanchís, J. Rodés‐Cabau, D. Arzamendi   +12 more
semanticscholar   +1 more source